IRAK4 modulators

Compounds of Formula 0, and stereoisomers and pharmaceutically acceptable salts thereof, as well as methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Katsumoto, Tamiko, Liang, Jun, Do, Steven, Rajapaksa, Naomi S, Bryan, Marian C, Fu, Liqiang, Kiefer, Jr., James Richard
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds of Formula 0, and stereoisomers and pharmaceutically acceptable salts thereof, as well as methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.